The FDA has approved the first at-home cervical cancer screening test, known as the Teal Wand. The test allows women to collect a sample at home with a swab, offering a less invasive alternative to a traditional pelvic exam. The test detects HPV, a major cause of cervical cancer, and could make screenings more accessible, especially for those who find doctor visits uncomfortable.
Though the test offers added convenience, experts stress the importance of following up with a doctor if the results are positive. The test is still prescribed through telehealth, and the sample is sent to a lab for analysis. While exact costs and insurance coverage are still uncertain, the test is expected to be covered by most insurance plans.
Although this at-home option is a step forward, experts say regular gynecological checkups are still crucial. The Teal Wand can help with early detection, but ongoing care is necessary for overall health and well-being.
SOURCE:
Source: Original Article
Publish Date: 2025-05-14 06:00:00